Agenda:

8:00 am – 8:30 am WELCOME & INTRODUCTION 
Prof. Rebecca Carrier, Professor and Associate Chair for Research, Chemical Engineering, Northeastern University
Dr. Cornell Stamoran, Founder, Catalent Institute

8:30 am – 9:05 am IMPORTANCE OF API CHARACTERIZATION FOR IMPROVING DEVELOPABILITY OF SMALL MOLECULES 
Dr. Chris Towler, Senior Fellow, Novartis Institutes for BioMedical Research

9:05 am – 9:40 am MODELING THE PHARMACOKINETIC CHALLENGES OF ORAL SMALL MOLECULE DRUGS 
Dr. Katarina Vulic, Senior Scientist, Novartis Institutes for BioMedical Research

9:40 am – 9:50 am BREAK

9:50 am – 10:30 am FORMULATION STRATEGIES TO OVERCOME ORAL BIOAVAILABILITY CHALLENGES OF SMALL MOLECULE DRUGS 
Mr. Stephen Tindal, Director, Science & Technology, Catalent Pharma Solutions

10:30 am – 11:05 am MECHANISTIC STUDIES AND MODELING TO PREDICT THE IMPACT OF LIPIDS ON ORAL ABSORPTION 
Prof. Rebecca Carrier, Northeastern University

11:05 am – 12:00 pm AUDIENCE APPLIED LEARNING CHALLENGE- PART 1 AM SPEAKERS

12:00 pm – 1:00 pm NETWORKING LUNCH & MEET THE EXPERTS

1:00 pm – 1:35 am CMC AND QUALITY CONSIDERATIONS

1:35 pm – 2:10 pm INSIGHTS AND STRATEGIES TO INCORPORATE PATIENT FOCUSED DESIGN 
Dr. Cornell Stamoran, Founder, Catalent Institute

2:10 pm – 2:45 pm STRATEGIES FOR PROGRESSING TO PHASE I FORMULATIONS TO IMPROVE YOUR SPEED TO AND SUCCESS IN THE CLINIC 
Dr. Manuel Sanchez-Felix, Senior Fellow, Novartis Institute for Biomedical Research

2:45 pm – 3:00 pm BREAK

3:00 pm – 4:00 pm AUDIENCE APPLIED LEARNING CHALLENGE- PART 2 PM SPEAKERS  CONCLUDING REMARKS 
Dr. Ronak Savla, Scientific Affairs Manager, Catalent Pharma Solutions